The Japanese Ministry of Health, Labor and Welfare has given Augmenix Shonin approval for its SpaceOAR system. The product is an absorbable hydrogel spacer designed to reduce risks of prostate cancer radiation treatment by separating the prostate from the rectal wall.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.